Home News Breaking News Briefs

Breaking News Briefs

Summaries of current approvals by global regulatory agencies of drugs and other treatment-related therapeutic agents used to treat lung cancer and other thoracic neoplasms.

Breaking News Briefs

Lorlatinib Approved for Second- or Third-Line Management of ALK-positive Metastatic NSCLC November 2, 2018—The U.S. Food and Drug Administration granted accelerated approval to lorlatinib...

Meeting News